🇺🇸 e.-coli-nissle in United States
2 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 2
Most-reported reactions
- Anaphylactic Reaction — 1 report (50%)
- Flushing — 1 report (50%)
Other Gastroenterology approved in United States
Frequently asked questions
Is e.-coli-nissle approved in United States?
e.-coli-nissle does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for e.-coli-nissle in United States?
GWT-TUD GmbH is the originator. The local marketing authorisation holder may differ — check the official source linked above.